Skip to main content
Premium Trial:

Request an Annual Quote

Verogen, Gene by Gene Strike Forensic Genetics Alliance

NEW YORK — Forensic DNA sequencing firm Verogen said on Monday that it has partnered with Gene by Gene to improve forensic investigative genetic genealogy (FIGG).

Under the terms of the deal, Gene by Gene will support DNA uploads generated by Verogen's ForenSeq Kintelligence genetic genealogy kit, which is expected to double the number of available FIGG profiles. Each company will also create algorithms and software designed to increase the probability of generating uploadable single nucleotide polymorphism profiles and lower bioinformatic costs enabling standardization of the FIGG workflow.

Additional terms were not disclosed.

"Currently, FIGG is expensive and slow," Verogen CEO Brett Williams said in a statement. "By applying database context to create best-in-class toolsets for commonly used methods, like imputation, and allowing labs to upload ForenSeq Kintelligence profiles to the Gene by Gene database, this partnership will drive an impactful shift in the efficiency and time of analysis."

About a year ago, San Diego-based Verogen began collaborating with Eurofins to implement next-generation sequencing into routine forensic casework. In early 2021, Houston-based Gene by Gene merged with direct-to-consumer DNA testing company MyDNA.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.